United States Human Coagulation Factor VII Sales Market Report 2021

August 2016 | 123 pages | ID: U03DEB8C9F1EN
QYResearch

Abstracts

This report studies sales (consumption) of Human Coagulation Factor VII in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Baxter
• Bayer
• Pfizer
• CSL
• Grifols
• Octapharma
• BPL
• Kedrion

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Recombinant Factor VIII
• Plasma-derived Factor VIII
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Human Coagulation Factor VII in each application, can be divided into

• Hemophilia A
• Spontanous + Traum
• Surgical

Contents

United States Human Coagulation Factor VII Sales Market Report 2021

1 HUMAN COAGULATION FACTOR VII OVERVIEW

1.1 Product Overview and Scope of Human Coagulation Factor VII
1.2 Classification of Human Coagulation Factor VII
  1.2.1 Recombinant Factor VIII
  1.2.2 Plasma-derived Factor VIII
  1.2.3 Type III
1.3 Applications of Human Coagulation Factor VII
  1.3.1 Hemophilia A
  1.3.2 Spontanous + Traum
  1.3.3 Surgical
1.4 USA Market Size (Value and Volume) of Human Coagulation Factor VII (2011-2021)
  1.4.1 USA Human Coagulation Factor VII Sales, Revenue and Price (2011-2021)
  1.4.2 USA Human Coagulation Factor VII Sales and Growth Rate (2011-2021)
  1.4.3 USA Human Coagulation Factor VII Revenue and Growth Rate (2011-2021)

2 USA HUMAN COAGULATION FACTOR VII COMPETITION BY MANUFACTURERS

2.1 USA Human Coagulation Factor VII Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Human Coagulation Factor VII Revenue and Share by Manufactures (2015 and 2016)

3 USA HUMAN COAGULATION FACTOR VII (VOLUME AND VALUE) BY TYPE

3.1 USA Human Coagulation Factor VII Sales and Market Share by Type (2011-2021)
3.2 USA Human Coagulation Factor VII Revenue and Market Share by Type (2011-2021)

4 USA HUMAN COAGULATION FACTOR VII (VOLUME) BY APPLICATION

5 USA HUMAN COAGULATION FACTOR VII MANUFACTURERS ANALYSIS

5.1 Baxter
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Coagulation Factor VII Product Type and Technology
    5.1.2.1 Recombinant Factor VIII
    5.1.2.2 Plasma-derived Factor VIII
  5.1.3 Human Coagulation Factor VII Sales, Revenue, Price of Baxter (2015 and 2016)
5.2 Bayer
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Recombinant Factor VIII
    5.2.2.2 Plasma-derived Factor VIII
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Bayer (2015 and 2016)
5.3 Pfizer
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Pfizer Product Type and Technology
    5.3.2.1 Recombinant Factor VIII
    5.3.2.2 Plasma-derived Factor VIII
  5.3.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.4 CSL
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Product Type and Technology
    5.4.2.1 Recombinant Factor VIII
    5.4.2.2 Plasma-derived Factor VIII
  5.4.3 CSL Sales, Revenue, Price of CSL (2015 and 2016)
5.5 Grifols
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Grifols Product Type and Technology
    5.5.2.1 Recombinant Factor VIII
    5.5.2.2 Plasma-derived Factor VIII
  5.5.3 Grifols Sales, Revenue, Price of Grifols (2015 and 2016)
5.6 Octapharma
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Octapharma Product Type and Technology
    5.6.2.1 Recombinant Factor VIII
    5.6.2.2 Plasma-derived Factor VIII
  5.6.3 Octapharma Sales, Revenue, Price of Octapharma (2015 and 2016)
5.7 BPL
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 BPL Product Type and Technology
    5.7.2.1 Recombinant Factor VIII
    5.7.2.2 Plasma-derived Factor VIII
  5.7.3 BPL Sales, Revenue, Price of BPL (2015 and 2016)
5.8 Kedrion
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Kedrion Product Type and Technology
    5.8.2.1 Recombinant Factor VIII
    5.8.2.2 Plasma-derived Factor VIII
  5.8.3 Kedrion Sales, Revenue, Price of Kedrion (2015 and 2016)

6 HUMAN COAGULATION FACTOR VII TECHNOLOGY AND DEVELOPMENT TREND

6.1 Human Coagulation Factor VII Technology Analysis
6.2 Human Coagulation Factor VII Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Coagulation Factor VII
Table Classification of Human Coagulation Factor VII
Figure USA Sales Market Share of Human Coagulation Factor VII by Type in 2015
Figure Recombinant Factor VIII Picture
Figure Plasma-derived Factor VIII Picture
Table Applications of Human Coagulation Factor VII
Figure USA Sales Market Share of Human Coagulation Factor VII by Application in 2015
Figure Hemophilia A Examples
Figure Spontanous + Traum Examples
Figure Surgical Examples
Table USA Human Coagulation Factor VII Sales, Revenue and Price (2011-2021)
Figure USA Human Coagulation Factor VII Sales and Growth Rate (2011-2021)
Figure USA Human Coagulation Factor VII Revenue and Growth Rate (2011-2021)
Table USA Human Coagulation Factor VII Sales of Key Manufacturers (2015 and 2016)
Table USA Human Coagulation Factor VII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Coagulation Factor VII Sales Share by Manufacturers
Figure 2016 Human Coagulation Factor VII Sales Share by Manufacturers
Table USA Human Coagulation Factor VII Revenue by Manufacturers (2015 and 2016)
Table USA Human Coagulation Factor VII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Human Coagulation Factor VII Revenue Share by Manufacturers
Table 2016 USA Human Coagulation Factor VII Revenue Share by Manufacturers
Table USA Human Coagulation Factor VII Sales and Market Share by Type (2011-2021)
Table USA Human Coagulation Factor VII Sales Share by Type (2011-2021)
Figure Sales Market Share of Human Coagulation Factor VII by Type (2011-2021)
Figure USA Human Coagulation Factor VII Sales Growth Rate by Type (2011-2021)
Table USA Human Coagulation Factor VII Revenue and Market Share by Type (2011-2021)
Table USA Human Coagulation Factor VII Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Human Coagulation Factor VII by Type (2011-2021)
Figure USA Human Coagulation Factor VII Revenue Growth Rate by Type (2011-2021)
Table USA Human Coagulation Factor VII Sales and Market Share by Application (2011-2021)
Table USA Human Coagulation Factor VII Sales Share by Application (2011-2021)
Figure Sales Market Share of Human Coagulation Factor VII by Application (2011-2021)
Figure USA Human Coagulation Factor VII Sales Growth Rate by Application (2011-2021)
Table Baxter Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of Baxter (2015 and 2016)
Table Bayer Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of Bayer (2015 and 2016)
Table Pfizer Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of Pfizer (2015 and 2016)
Table CSL Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of CSL (2015 and 2016)
Table Grifols Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of Grifols (2015 and 2016)
Table Octapharma Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of Octapharma (2015 and 2016)
Table BPL Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of BPL (2015 and 2016)
Table Kedrion Basic Information List
Table Human Coagulation Factor VII Sales, Revenue, Price of Kedrion (2015 and 2016)